PTGS2 and breast cancer: harnessed the tumor homing ability of MSCs to construct miR-379-enriched MSC-EVs, which could significantly inhibit BC tumor growth and promote necrosis, depending on the regulation of cyclooxygenase-2 (COX-2) expression (29).